Improvement in lipid profile of the patients with saxagliptin as add on therapy to metformin in patients of type 2 DM who were previously on metformin alone with uncontrolled diabetes

Abstract

Introduction Diabetes is characterized by chronic hyperglycemia and disturbances of carbohydrate lipid and protein metabolism This study is an attempt to show an improvement in lipid profile TC TG LDL and HDL in patients of type 2 diabetes mellitus who were previously on metformin monotherapy with uncontrolled diabetesMaterial and method A total of 30 patients were enrolled who were on metformin monotherapy and with uncontrolled diabetes Patients were given metformin 500 mg twice a day and saxagliptin 25 mg once a dayPatients were followed up at 1st 3rd and 6th month and lipid profile TC TG LDL and HDL estimation was done during the follow up periodResults The mean age plusmn SD in male and female patients was 6142 yrs plusmn 699 and 5593 yrs plusmn 574 respectively The mean change in value from baseline at 24 weeks was TC 966 TG 940 LDL 1487 HDL 563 A highly significant difference has been seen at 0 vs 1 0 vs 3 and 0 vs 6 months in TC TG LDL and HDL valuesConclusion Saxagliptin has shown an improvement in lipid profile TC TG LDL HDL during 6 months of treatment in patients of type 2 DMKeywords Saxagliptin Uncontrolled type 2DM Metformin Lipid profile

Authors and Affiliations

Akshay Dahiwele, Dinesh Kansal, Dheeraj Kapoor, Parveen Sharma

Keywords

Related Articles

Role of renin angiotensin system in ischemic preconditioning

Cardiovascular diseases are the leading cause of morbidity and mortality. Angiotensin has been noted down that enhance cardioprotection of ischemic preconditioning (IPC). Ischemia is a state of oxygen deprivation in tiss...

Improvement in lipid profile of the patients with saxagliptin as add on therapy in patients of uncontrolled type 2 DM who were on metformin alone

Introduction: Diabetes is characterized by chronic hyperglycemia and deranged carbohydrate, lipid and protein metabolism. This study shows an improvement in lipid profile (TC, TG, LDL and HDL) with saxagliptin in patient...

Extemporaneous compounding: Cautions, controversies and convenience

Pharmacists are only knowledgeable and skilled healthcare professionals dedicated to compounding and preparing medications to meet the unique needs of patients The safe and effective extemporaneous compounding of prescri...

Pharmacokinetic interaction of Phosphorus on the treatment of sputum positive pulmonary tuberculosis patients

Tuberculosis (TB) in children is a neglected aspect of the TB epidemic despite it constituting 20% or more of all TB cases in many countries with high TB incidence. Tuberculosis constitutes a serious global health proble...

The role of predictive variables, in parents having children with conduct disorder

Introduction: Conduct Disorder in children may cause several psychosocial problems in their parents. Developing an understanding of the predictive role of variables that affect the psycho social problems and how it diffe...

Download PDF file
  • EP ID EP481702
  • DOI 10.18231/2456-9542.2018.0003
  • Views 92
  • Downloads 0

How To Cite

Akshay Dahiwele, Dinesh Kansal, Dheeraj Kapoor, Parveen Sharma (2018). Improvement in lipid profile of the patients with saxagliptin as add on therapy to metformin in patients of type 2 DM who were previously on metformin alone with uncontrolled diabetes. IP International Journal of Comprehensive and Advanced Pharmacology, 3(1), 10-12. https://europub.co.uk/articles/-A-481702